Neuspera fetches $26 mln Series B
San Jose, California-based Neuspera Medical Inc, a neuromodulation company, has secured $26 million in Series B funding. The company's investors include 6 Dimensions Capital, Action Potential Venture Capital, Windham Venture Partners, Delta Capital, LLC and Purple Arch Ventures.
20 February 2019•1 min read
